MTaI in News
बीमारी हो या चोट, सर्जरी करेगा रोबोट!
#AapkiKhabarAapkaFayda में देखिए बीमारी हो या चोट, सर्जरी करेगा रोबोट! दिल हो या दिमाग, रोबोट करेगा इलाज! मस्क का दावा:सर्जन घटेंगे, रोबोट बढ़ेंगे रोबोट बनेंगे मशीन युग में नए 'मसीहा'! 'डॉ. रोबो' पर कितना करें भरोसा? #AapkiKhabarAapkaFayda Source:- Zee...
Opportunity in crisis? India’s medical device sector eyes post tariffs world
In a recent webinar hosted by ETHealthworld, industry experts examined the implications of recent US developments on Source:- ET Healthworld
Webinar on Tariffs Trade offs Can Indian Device Makers Hold Ground Amid Global Trade Strain
At a time when the Indian medical device industry is being hailed as a sunrise sector, with domestic manufacturers eyeing the US as a key market Source:- YouTube
US harming its own citizens by putting excessive tariffs on medical technology: MTaI
US President Donald Trump has announced reciprocal tariffs on about 60 countries to counter higher duties imposed globally on American products. Pavan Choudary, Chairman, Medical Technology Association of India (MTaI) said that the U.S. administration’s decision to...
Indian medical devices industry calls USA’s 27% tariff challenge for growth
Indian medical device manufacturers expect challenges for their growth in the United States (US) after President Donald Trump announced imposing a 27 per cent reciprocal tariff on imports from India. The new tariffs may impact India Source:- Business Standard
Indian Med Device makers face stiff test as US tariffs take effect, eyes diplomatic escape
Over the recent tariff announced by the US President, industry bodies in India have called the move a significant challenge to the sector's growth and stakeholders have voiced to explore bilateral routes for a balanced approach to serve mutual interest. Source:- ET...
Medtech sectors views US tariff hike as barrier to growth
US President Donald Trump announced tariffs on April 2, 2025 as part of his “Liberation Day” economic plan. The tariffs include a 26 per cent reciprocal duty on Indian imports. The Trump administration exempted pharmaceutical exports from the tariff, but medical...
No tariffs on Indian pharma; plays vital role in supplying affordable medicines to US
The Trump administration has exempted the Indian pharma sector from reciprocal tariffs, recognising the vital role played by the domestic industry in supplying affordable medicines across the globe, including the US, . Source:- Zee Business
US flays India’s drug price controls
The US report criticizes India’s drug price controls on medical devices like stents and knee implants, citing concerns over inflation adjustments and tech innovations, impacting US companies’ market participation. Source:- Financial Express
